Literature DB >> 20058047

Long-term effects of a sensitisation campaign on migraine: the Casilino study.

B Petolicchio1, L Di Clemente, M Altieri, E Vicenzini, G L Lenzi, Vittorio Di Piero.   

Abstract

In 2003, we conducted a sensitisation campaign on migraine in the Casilino district of Rome, by sending a letter with the ID Migraine test to all the households and placing posters in the GPs' waiting room. Out of 195 headache patients recruited, 92% had migraine while 73% had never consulted a physician for headache. The aim of this study was to evaluate the long-term impact of this campaign. The follow-up was performed by a telephone interview. The questionnaire considered the characteristics of headache, quality of life, preventive and acute treatments, drug efficacy, comorbidity and subjective usefulness of the campaign. Of the 179 migraineurs, 90.5% (mean age 40.7 +/- 16.5, 139 females) were included in the follow-up. An improvement was observed in mean pain intensity (-13.9%; p < 0.0001) and mean HIT-6 score (-6.1%; p = 0.0003). The campaign was considered to be useful by 63.6% of cases, while 66.1% reported an improvement in their clinical status. Improved patients showed a decreased mean number of days with headache per month (-51.7%; p < 0.0001), pain intensity (-21.8%; p < 0.0001), headache duration (-18.1%; p = 0.0008)and HIT-6 score (-11.7%; p < 0.0001). Our data suggest that the effects of a "single shot" campaign are beneficial not only in a short-term perspective, but even in the longterm. Moreover, the lack of benefit in more severe cases suggests that such patients should not be treated by GPs alone: patients in whom the HIT-6 score, frequency,severity or duration of headache worsen should be promptly referred to the headache clinic.

Entities:  

Mesh:

Year:  2010        PMID: 20058047      PMCID: PMC3452285          DOI: 10.1007/s10194-009-0183-6

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  29 in total

1.  An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs.

Authors:  M Roncolato; L Fabbri; G Recchia; L Cavazzuti; G Visona; O Brignoli; G Medea
Journal:  Eur Neurol       Date:  2000       Impact factor: 1.710

2.  Migraine in the United States: epidemiology and patterns of health care use.

Authors:  R B Lipton; A I Scher; K Kolodner; J Liberman; T J Steiner; W F Stewart
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

3.  Prevalence and description of chronic daily headache in the general population in France.

Authors:  Michel Lantéri-Minet; Jean-Paul Auray; Abdelkader El Hasnaoui; Jean-François Dartigues; Gérard Duru; Patrick Henry; Christian Lucas; André Pradalier; Guy Chazot; Anne-Françoise Gaudin
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

4.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Authors:  M D Ferrari; P J Goadsby; K I Roon; R B Lipton
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

6.  Self-awareness of migraine: interpreting the labels that headache sufferers apply to their headaches.

Authors:  Richard B Lipton; Walter F Stewart; Joshua N Liberman
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

7.  A self-administered screener for migraine in primary care: The ID Migraine validation study.

Authors:  R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  Headache management program improves outcome for chronic headache.

Authors:  Linda H Harpole; Gregory P Samsa; Annette E Jurgelski; Janice L Shipley; Allan Bernstein; David B Matchar
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

9.  Center of excellence for headache care: group model at Kaiser Permanente.

Authors:  Andrew Blumenfeld; Marie Tischio
Journal:  Headache       Date:  2003-05       Impact factor: 5.887

10.  Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.

Authors:  S Cevoli; D D'Amico; P Martelletti; F Valguarnera; E Del Bene; R De Simone; P Sarchielli; Mc Narbone; L Testa; S Genco; G Bussone; P Cortelli
Journal:  Cephalalgia       Date:  2009-05-11       Impact factor: 6.292

View more
  1 in total

1.  A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers-Danlos syndrome, hypermobility type.

Authors:  Francesca Puledda; Alessandro Viganò; Claudia Celletti; Barbara Petolicchio; Massimiliano Toscano; Edoardo Vicenzini; Marco Castori; Guido Laudani; Donatella Valente; Filippo Camerota; Vittorio Di Piero
Journal:  Neurol Sci       Date:  2015-03-20       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.